dHMN-6

IGHMBP2 | 2001

What Is dHMN-6?

dHMN-6 is a type of CMT caused by autosomal recessive mutations in the IGHMBP2 gene. This gene provides instructions for making a protein involved in the processing of genetic material within motor nerve cells. Mutations in the IGHMBP2 gene disrupt this function, leading to impaired nerve signal transmission.

dHMN-6 is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in dHMN-6 is variable, ranging from childhood to adulthood. As a motor neuropathy, dHMN-6 primarily affects the most distal points, with weakness and atrophy of the feet and hands, and little to no involvement of the sensory nerves. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

dHMN-6 symptoms may include:

  • Weakness and atrophy in the feet and lower legs
  • Foot drop
  • Reduced or absent reflexes
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

dHMN-6 shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
dHMN-6

Classification
dHMN/HMN

Subtype Alias
dSMA-1

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
IGHMBP2

Gene Full Name
Immunoglobulin Mu DNA Binding Protein 2

Chromosome
11q13.3

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Biallelic

Confidence:
High

Prediction:
The literature predicts a biallelic loss-of-function mechanism for dHMN-6 (SMARD1): pathogenic IGHMBP2 variants reduce or abolish ATPase and helicase activity, with disease requiring two defective copies and residual activity correlating with milder phenotypes. Restored wild-type IGHMBP2 is predicted to rescue, consistent with recessive loss rather than a dominant-negative effect.

Rationale:
Biallelic IGHMBP2 alleles lose ATPase and helicase activity, with residual function tracking milder disease, so restored wild-type is predicted to rescue: a recessive loss of function.

ClinVar Pathogenic Variants

View dHMN-6 ClinVar Variants

dHMN-6 OMIM Entry

dHMN-6 OMIM

IGHMBP2 OMIM Entry

IGHMBP2 OMIM

More Info

dHMN-6 Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Mutations in the Gene Encoding Immunoglobulin Mu-Binding Protein 2 Cause Spinal Muscular Atrophy with Respiratory Distress Type 1

Authors

Grohmann, K., Schuelke, M., Diers, A., Hoffmann, K., Lucke, B., Adams, C., Bertini, E., Leonhardt-Horti, H., Muntoni, F., Ouvrier, R., Pfeufer, A., Rossi, R., Van Maldergem, L., Wilmshurst, J. M., Wienker, T. F., Sendtner, M., Rudnik-Schöneborn, S., Zerres, K., & Hübner, C.

Publication Date
August 13, 2001

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Jean-Martin Charcot lecturing at the Salpêtrière while comparing anatomical illustrations of a cavovarus Charcot-Marie-Tooth (CMT) foot and a Charcot neuroarthropathy foot, highlighting two different conditions that share the Charcot name.


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.